Experience

TVAX Biomedical, Inc.
• United States
• Biotechnology Research
• 1 - 100 Employee
• Senior Director of Manufacturing

  • Mar 2023 - Present

Merck
• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee
• Director Of Operations

  • Sep 2020 - Mar 2023


KindredBio

• United States
• Biotechnology Research
• 1 - 100 Employee

• Director of Process Development and Biomanufacturing

  • Aug 2018 - Sep 2020

  Responsible for GMP manufacturing of monoclonal antibodies and recombinant proteins Upstream Production of up to 2000L in single use bioreactors and downstream purification Responsible for process development of both upstream and downstream processes for protein therapeutics Responsible for transfer of processes into GMP manufacturing Responsible for GMP manufacturing of monoclonal antibodies and recombinant proteins Upstream Production of up to 2000L in single use bioreactors and downstream purification Responsible for process development of both upstream and downstream processes for protein therapeutics Responsible for transfer of processes into GMP manufacturing



Boehringer Ingelheim Animal Health - US

• Associate Director

  • Oct 2015 - Aug 2018

  • Associate Director of Research Early Development group • Managed process development group across 2 sites (St. Joseph, MO and Fort Dodge IA) • Developed scalable processes for both viral and bacterial vaccine antigens. These included both adherent and suspension cell lines. • Managed the laying down and coordination of testing of master seeds and master cells • Provide clinical material for Proof of Concept Studies • Associate Director of Research Early Development group • Managed process development group across 2 sites (St. Joseph, MO and Fort Dodge IA) • Developed scalable processes for both viral and bacterial vaccine antigens. These included both adherent and suspension cell lines. • Managed the laying down and coordination of testing of master seeds and master cells • Provide clinical material for Proof of Concept Studies



Zoetis Inc.

• United States
• Legal Services
• 1 - 100 Employee

• Senior Principal Scientist

  • Jul 2014 - Oct 2015

  • Managed cell line development group (5 FTE) • Responsible for generating cell lines and upstream process development (CHO cell lines) • Introduced new technologies to improve both cell line selection and upstream development • Provide clinical material from small to mid-scale batch size (5L-250L bioreactors) • Managed tech transfer of bioreactor processes to both internal and external pilot groups • Led transition of therapeutic mAb project into development and manufacturing • Managed cell line development group (5 FTE) • Responsible for generating cell lines and upstream process development (CHO cell lines) • Introduced new technologies to improve both cell line selection and upstream development • Provide clinical material from small to mid-scale batch size (5L-250L bioreactors) • Managed tech transfer of bioreactor processes to both internal and external pilot groups • Led transition of therapeutic mAb project into development and manufacturing



Zoetis

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Principal Scientist

  • Feb 2013 - Jul 2014

  I run a mammalian expression group as well as the cell line development group. I am also involved in antibody/protein engineering work. I run a mammalian expression group as well as the cell line development group. I am also involved in antibody/protein engineering work.



Pfizer Animal Health

• Principal Scientist

  • Dec 2010 - Jan 2013

  Protein engineeringMammalian cell expressionCell line development

• Senior Scientist

  • Feb 2010 - Dec 2010

  Protein engineeringMammalian cell expressionCell line development



Pfizer

• Events Services
• 1 - 100 Employee

• Senior Scientist

  • Aug 2007 - Feb 2010

  Was the biotherapeutics lead on a monoclonal antibody project (Oncology), which has transitioned from lead generation into clinical development. Provided cloning, purification, and characterization expertise for multiple antibody projects. Engineered IgG2 antibodies for increased disulfide isomer homogeneity. Engineered IgG1 antibodies for increased ADCC activity and correlated function with thermostability. Managed mammalian cell expression lab with 12 WAVE bioreactors. Directly supervised two scientists in expression lab. Show less